Detalles de la búsqueda
1.
Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study.
Support Care Cancer
; 28(7): 3093-3101, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659445
2.
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 20(11): 1518-1530, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578173
3.
Fatigue, treatment satisfaction and health-related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate-resistant prostate cancer.
Eur J Cancer Care (Engl)
; 28(1): e12949, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408244
4.
Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison.
Adv Ther
; 39(1): 518-531, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797506
5.
Real world treatment utilization patterns in patients with castration-resistant prostate cancer.
Scand J Urol
; 55(4): 299-306, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34096469
6.
Trophectoderm biopsy protocols can affect clinical outcomes: time to focus on the blastocyst biopsy technique.
Fertil Steril
; 113(5): 981-989, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32204876
7.
Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer.
Adv Ther
; 37(1): 512-526, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31813087
8.
Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer.
Adv Ther
; 37(1): 501-511, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31813086
9.
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis.
Leuk Lymphoma
; 60(1): 151-162, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407092
10.
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis.
Clin Lymphoma Myeloma Leuk
; 18(3): 163-173.e6, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29456035
11.
Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
Clin Ther
; 39(4): 723-737, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28366592
Resultados
1 -
11
de 11
1
Próxima >
>>